1st. of all, hand is held high to let you know I'm a BOD...

1st. of all, hand is held high to let you know I'm a BOD newbie.
I remember @Keith2 mentioning that BOD is a bit "leaky" when it comes to market sensitive announcements. Look at the recent downward SP movement, most likely from FY23 results, but hey.

One thing I am confident of is if the CAN REST trial is negative, then the rest of the world can pack up shop in trying to provide evidence of CBD demonstrating efficacy for insomnia. This was a rigorous world class study. My vibe is that it will be positive, but that's all I've got, the vibe.